Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $6.8912 (2.55%) ($6.6616 - $6.9600) on Wed. Nov. 20, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.66% (three month average) | RSI | 64 | Latest Price | $6.8912(2.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -1.3% a day on average for past five trading days. | Weekly Trend | EYES advances 5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(8%) UNG(8%) IGOV(7%) FIVG(4%) ICLN(4%) | Factors Impacting EYES price | EYES will decline at least -1.83% in a week (0% probabilities). BND(-8%) XLP(-6%) XLK(-6%) QQQ(-6%) LQD(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.83% (StdDev 3.66%) | Hourly BBV | 0 () | Intraday Trend | 2.5% | | | |
|
5 Day Moving Average | $6.9(-0.13%) | 10 Day Moving Average | $6.97(-1.13%) | 20 Day Moving Average | $6.67(3.32%) | To recent high | -10.3% | To recent low | 18.7% | Market Cap | $2.201b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |